PedAM
Pediatric Disease Annotations & Medicines
| Disease | hyperuricemia |
| Phenotype | C0022661|chronic kidney disease |
| Sentences | 11 |
| PubMedID- 24433285 | The feather (febuxostat versus placebo randomized controlled trial regarding reduced renal function in patients with hyperuricemia complicated by chronic kidney disease stage 3) study is a prospective, multicenter, double-blind, randomized, placebo-controlled trial of febuxostat—a novel, nonpurine, selective, xanthine oxidase inhibitor. |
| PubMedID- 24152124 | Febuxostat for treating allopurinol-resistant hyperuricemia in patients with chronic kidney disease. |
| PubMedID- 21547469 | hyperuricemia is associated with chronic kidney disease, arterial hypertension, coronary artery and heart disease, cerebrovascular disease and diabetes mellitus. |
| PubMedID- 25210423 | Febuxostat for hyperuricemia in patients with advanced chronic kidney disease. |
| PubMedID- 21783292 | Background: hyperuricemia is common in patients with chronic kidney disease (ckd). |
| PubMedID- 22948067 | Gender difference in the association of hyperuricemia with chronic kidney disease in southern china. |
| PubMedID- 21694941 | Other factors that may contribute to the relatively low rate of hyperuricemia and gout in patients with chronic kidney disease (ckd) include lower protein intake and increased intestinal clearance of uric acid. |
| PubMedID- 23960345 | This is a retrospective cohort study in chronic kidney disease (ckd) patients with hyperuricemia from 1998 to 2008. |
| PubMedID- 25685556 | Although hyperuricemia is common in patients with chronic kidney disease, the impact of uric acid on mortality and cv events remains unclear. |
| PubMedID- 21722384 | Background: hyperuricemia is prevalent in patients with chronic kidney disease (ckd). |
| PubMedID- 26297226 | In the multivariable cox proportional hazard analyses after adjustment for several confounding factors including chronic kidney disease and use of diuretics, hyperuricemia was an independent predictor of all-cause mortality (hazard ratio 1.98, 95% confidence interval 1.036-3.793, p = 0.039). |
Page: 1